ADVANCED UROTHELIAL CARCINOMA
Clinical trials for ADVANCED UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug combo enters first human tests
Disease control Recruiting nowThis early-stage trial tests a new oral drug, FX-909, alone or with pembrolizumab, in people with advanced solid tumors like bladder cancer. The main goals are to check safety and find the right dose. About 120 adults will take the drug daily and have regular scans and blood test…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New combo therapy aims to keep advanced bladder cancer at bay
Disease control Recruiting nowThis study tests a two-step treatment for people with advanced bladder cancer that has spread. First, patients receive a combination of two drugs (enfortumab vedotin and pembrolizumab) for 18 weeks. Then, those who respond well continue with just pembrolizumab for up to 2 years t…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New hope for advanced bladder cancer: targeted drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug (trastuzumab rezetecan) alone or with an immunotherapy (adebrelimab) in 96 adults with advanced or metastatic bladder cancer that has the HER2 protein. The goal is to see if the treatment shrinks tumors and how long it keeps the cancer from growing. Pa…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 04, 2026 16:22 UTC